TABLE 1.
Patient characteristics
| All (n = 50) | OR (N = 10) | nOR (N = 40) | P‐value | |
|---|---|---|---|---|
| Age (y) | ||||
| Median [range] | 62.5 [36.0, 78.0] | 64.0 [54.0, 78.0] | 65.0 [36.0, 76.0] | .622 |
| Sex n(%) | ||||
| Female | 29 (58.0) | 6 (60.0) | 23 (57.5) | 1 |
| Male | 31 (42.0) | 4 (40.0) | 17 (42.5) | |
| Grade n (%) | ||||
| 1 | 12 (24.0) | 1 (10.0) | 11 (29.7) | .532 |
| 2 | 23 (46.0) | 6 (60.0) | 17 (45.9) | |
| 3a | 12 (24.0) | 3 (30.0) | 9 (24.3) | |
| Stage n (%) | ||||
| Ⅱ | 3 (6.00) | 0 (00.0) | 3 (7.50) | .036 |
| Ⅲ | 17 (34.0) | 7 (70.0) | 10 (25.0) | |
| Ⅳ | 30 (60.0) | 3 (30.0) | 27 (67.5) | |
| B symptoms n (%) | 9 (18.0) | 3 (30.0) | 6 (18.2) | 1 |
| Bone marrow involvement n (%) | 27 (54.0) | 4 (30.8) | 23 (57.5) | .164 |
| Bulky disease >7 cm n (%) | 18 (36.0) | 0 (0.00) | 18 (45.0) | .009 |
| GELF criteria | ||||
| Low | 2 (4.00) | 1 (10.0) | 1 (2.50) | .363 |
| FLIPI n (%) | ||||
| Low | 3 (6.00) | 1 (10.0) | 2 (5.00) | .07 |
| Intermediate | 22 (44.0) | 7 (70.0) | 15 (37.5) | |
| High | 25 (50.0) | 2 (20.0) | 23 (57.5) | |
| FLIPI‐2 n (%) | ||||
| Low | 0 (0.00) | 0 (0.00) | 0 (0.00) | .308 |
| Intermediate | 27 (54.0) | 7 (70.0) | 20 (50.0) | |
| High | 23 (46.0) | 3 (30.0) | 20 (50.0) | |